Dialysis Access Maintenance: Plain Balloon Angioplasty.
Access maintenance
Angioplasty
Arteriovenous fistula
Balloon dilatation
Haemodialysis
Percutaneous transluminal angioplasty
Journal
Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
14
12
2022
accepted:
31
03
2023
medline:
4
9
2023
pubmed:
9
5
2023
entrez:
8
5
2023
Statut:
ppublish
Résumé
Plain balloon angioplasty remains the first-line treatment for dialysis access stenosis. This chapter reviews the outcomes of plain balloon angioplasty from cohort studies and comparative studies. Angioplasty outcomes are more favourable in arteriovenous fistulae (AVF) compared to arteriovenous grafts (AVG) with primary patency at 6 months ranging from 42-63% compared to 27-61%, respectively, and improved for forearm fistulae compared with upper arm fistulae. Higher pressures are required to treat stenoses in AVFs compared to AVGs. Outcomes are worse in more severe stenoses, increased patient age, previous interventions and fistulae that develop early stenoses. Major complication rates following angioplasty in dialysis access are between 3 and 5%. Repeat treatments and the use of adjuncts such as drug-coated balloons and stents can prolong the patency of dialysis access. Level of Evidence No level of evidence (Review paper).
Identifiants
pubmed: 37156943
doi: 10.1007/s00270-023-03441-x
pii: 10.1007/s00270-023-03441-x
pmc: PMC10471649
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1136-1143Informations de copyright
© 2023. The Author(s).
Références
Lumsden AB, MacDonald MJ, Kikeri DK, Harker LA, Allen RC. Hemodialysis access graft stenosis: percutaneous transluminal angioplasty. J Surg Res. 1997;68(2):181–5.
pubmed: 9184678
doi: 10.1006/jsre.1997.5060
Roy-Chaudhury P, Wang Y, Krishnamoorthy M, Zhang J, Banerjee R, Munda R, Heffelfinger S, Arend L. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transpl. 2009;24(9):2786–91.
doi: 10.1093/ndt/gfn708
Manns B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach S, Radkevich V, Murphy B. Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol. 2005;16(1):201–9.
pubmed: 15563567
doi: 10.1681/ASN.2004050355
Viecelli AK, Tong A, O’Lone E, Ju A, Hanson CS, Sautenet B, Craig JC, Manns B, Howell M, Chemla E, et al. Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop on establishing a core outcome measure for hemodialysis vascular access. Am J Kidney Dis. 2018;71(5):690–700.
pubmed: 29478866
doi: 10.1053/j.ajkd.2017.12.003
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, Allon M, Asif A, Astor BC, Glickman MH, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4 Suppl 2):S1–164.
pubmed: 32778223
doi: 10.1053/j.ajkd.2019.12.001
Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int. 1992;42(6):1390–7.
pubmed: 1474770
doi: 10.1038/ki.1992.431
Dapunt O, Feurstein M, Rendl KH, Prenner K. Transluminal angioplasty versus conventional operation in the treatment of haemodialysis fistula stenosis: results from a 5-year study. Br J Surg. 1987;74(11):1004–5.
pubmed: 2961397
doi: 10.1002/bjs.1800741116
Glanz S, Gordon D, Butt KM, Hong J, Adamson R, Sclafani SJ. Dialysis access fistulas: treatment of stenoses by transluminal angioplasty. Radiology. 1984;152(3):637–42.
pubmed: 6235537
doi: 10.1148/radiology.152.3.6235537
Tessitore N, Mansueto G, Lipari G, Bedogna V, Tardivo S, Baggio E, Cenzi D, Carbognin G, Poli A, Lupo A. Endovascular versus surgical preemptive repair of forearm arteriovenous fistula juxta-anastomotic stenosis: analysis of data collected prospectively from 1999 to 2004. Clin J Am Soc Nephrol. 2006;1(3):448–54.
pubmed: 17699244
doi: 10.2215/CJN.01351005
Gray RJ, Sacks D, Martin LG, Trerotola SO, Society of Interventional Radiology Technology Assessment C. Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol. 2003,14(9 Pt 2):S433–42
Manninen HI, Kaukanen ET, Ikaheimo R, Karhapaa P, Lahtinen T, Matsi P, Lampainen E. Brachial arterial access: endovascular treatment of failing Brescia-Cimino hemodialysis fistulas–initial success and long-term results. Radiology. 2001;218(3):711–8.
pubmed: 11230644
doi: 10.1148/radiology.218.3.r01mr38711
Turmel-Rodrigues L, Pengloan J, Rodrigue H, Brillet G, Lataste A, Pierre D, Jourdan JL, Blanchard D. Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology. Kidney Int. 2000;57(3):1124–40.
pubmed: 10720965
doi: 10.1046/j.1523-1755.2000.00940.x
Clark TW, Hirsch DA, Jindal KJ, Veugelers PJ, LeBlanc J. Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas. J Vasc Interv Radiol. 2002;13(1):51–9.
pubmed: 11788695
doi: 10.1016/S1051-0443(07)60009-8
Trerotola SO, Kwak A, Clark TW, Mondschein JI, Patel AA, Soulen MC, Stavropoulos SW, Shlansky-Goldberg RD, Solomon JA, Tuite CM, et al. Prospective study of balloon inflation pressures and other technical aspects of hemodialysis access angioplasty. J Vasc Interv Radiol. 2005;16(12):1613–8.
pubmed: 16371527
doi: 10.1097/01.RVI.0000183588.57568.36
Vesely TM, Pilgram TK. Angioplasty balloon inflation pressures during treatment of hemodialysis graft-related stenoses. J Vasc Interv Radiol. 2006;17(4):623–8.
pubmed: 16614144
doi: 10.1097/01.RVI.0000208988.28121.AB
Elramah M, Boujelbane L, Yevzlin AS, Wakeen M, Astor BC, Chan MR. Dialysis access venous stenosis: treatment with balloon angioplasty 30-second vs. 1-minute inflation times. Hemodial Int. 2015;19(1):108–14.
pubmed: 24888749
doi: 10.1111/hdi.12183
Forauer AR, Hoffer EK, Homa K. Dialysis access venous stenoses: treatment with balloon angioplasty—1-versus 3-minute inflation times. Radiology. 2008;249(1):375–81.
pubmed: 18796688
doi: 10.1148/radiol.2491071845
Leontiev O, Shlansky-Goldberg RD, Stavropoulos SW, Mondschein JI, Itkin M, Clark TW, Trerotola SO. Should all inflow stenoses be treated in failing autogenous hemodialysis fistulae? J Vasc Interv Radiol. 2014;25(4):542–7.
pubmed: 24508347
doi: 10.1016/j.jvir.2013.12.566
Gelbfish GA. Clinical surveillance and monitoring of arteriovenous access for hemodialysis. Tech Vasc Interv Radiol. 2008;11(3):156–66.
pubmed: 19100944
doi: 10.1053/j.tvir.2008.09.002
Bountouris I, Kristmundsson T, Dias N, Zdanowski Z, Malina M. Is repeat PTA of a failing hemodialysis Fistula durable? Int J Vasc Med. 2014;2014: 369687.
pubmed: 24587906
pmcid: 3920629
Heye S, Maleux G, Vaninbroukx J, Claes K, Kuypers D, Oyen R. Factors influencing technical success and outcome of percutaneous balloon angioplasty in de novo native hemodialysis arteriovenous fistulas. Eur J Radiol. 2012;81(9):2298–303.
pubmed: 21955605
doi: 10.1016/j.ejrad.2011.09.004
Kanterman RY, Vesely TM, Pilgram TK, Guy BW, Windus DW, Picus D. Dialysis access grafts: anatomic location of venous stenosis and results of angioplasty. Radiology. 1995;195(1):135–9.
pubmed: 7892454
doi: 10.1148/radiology.195.1.7892454
Manou-Stathopoulou S, Robinson EJ, Harvey JJ, Karunanithy N, Calder F, Robson MG. Factors associated with outcome after successful radiological intervention in arteriovenous fistulas: a retrospective cohort. J Vasc Access. 2019;20(6):716–24.
pubmed: 31084389
pmcid: 6856953
doi: 10.1177/1129729819845991
Rajan DK, Bunston S, Misra S, Pinto R, Lok CE. Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty—are there clinical predictors of patency? Radiology. 2004;232(2):508–15.
pubmed: 15286321
doi: 10.1148/radiol.2322030714
Safa AA, Valji K, Roberts AC, Ziegler TW, Hye RJ, Oglevie SB. Detection and treatment of dysfunctional hemodialysis access grafts: effect of a surveillance program on graft patency and the incidence of thrombosis. Radiology. 1996;199(3):653–7.
pubmed: 8637982
doi: 10.1148/radiology.199.3.8637982
Rajan DK, Clark TW. Patency of Wallstents placed at the venous anastomosis of dialysis grafts for salvage of angioplasty-induced rupture. Cardiovasc Interv Radiol. 2003;26(3):242–5.
doi: 10.1007/s00270-003-2706-x
Neuen BL, Gunnarsson R, Baer RA, Tosenovsky P, Green SJ, Golledge J, Mantha ML. Factors associated with patency following angioplasty of hemodialysis fistulae. J Vasc Interv Radiol. 2014;25(9):1419–26.
pubmed: 25000824
doi: 10.1016/j.jvir.2014.05.020
Holden A, Haruguchi H, Suemitsu K, Isogai N, Ross J, Hull J, Wang H, Seamans J, Lookstein R, Investigators IPAA. IN.PACT AV access randomized trial: 12-month clinical results demonstrating the sustained treatment effect of drug-coated balloons. J Vasc Interv Radiol. 2022;33(8):884–894.e887
Karmota AG. Paclitaxel coated-balloon (PCB) versus standard plain old balloon (POB) fistuloplasty for failing dialysis access. Ann R Coll Surg Engl. 2020;102(8):601–5.
pubmed: 32538115
pmcid: 7538728
doi: 10.1308/rcsann.2020.0121
Karunanithy N, Robinson EJ, Ahmad F, Burton JO, Calder F, Coles S, Das N, Dorling A, Forman C, Jaffer O, et al. A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulas. Kidney Int. 2021;100(2):447–56.
pubmed: 33781793
doi: 10.1016/j.kint.2021.02.040
Lookstein RA, Haruguchi H, Holden A. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. Reply. N Engl J Med. 2021;384(12):1173–4.
pubmed: 33761220
Maleux G, Vander Mijnsbrugge W, Henroteaux D, Laenen A, Cornelissen S, Claes K, Fourneau I, Verbeeck N. Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae. J Vasc Interv Radiol. 2018;29(4):470–75 e473
Moreno-Sanchez T, Moreno-Ramirez M, Machancoses FH, Pardo-Moreno P, Navarro-Vergara PF, Garcia-Revillo J. Efficacy of paclitaxel balloon for hemodialysis stenosis fistulae after one year compared to high-pressure balloons: a controlled, multicentre, randomized trial. Cardiovasc Intervent Radiol. 2020;43(3):382–90.
pubmed: 31722055
doi: 10.1007/s00270-019-02372-w
Trerotola SO, Lawson J, Roy-Chaudhury P, Saad TF, Lutonix AVCTI. Drug coated balloon angioplasty in failing AV fistulas: a randomized controlled trial. Clin J Am Soc Nephrol. 2018;13(8):1215–24
Trerotola SO, Saad TF, Roy-Chaudhury P, Lutonix AVCTI. The lutonix AV randomized trial of paclitaxel-coated balloons in arteriovenous fistula stenosis: 2-year results and subgroup analysis. J Vasc Interv Radiol. 2020; 31(1):1–14 e15.
Yin Y, Shi Y, Cui T, Li H, Chen J, Zhang L, Yu Z, Li H, Yan Y, Wu K et al. Efficacy and safety of paclitaxel-coated balloon angioplasty for dysfunctional arteriovenous fistulas: a multicenter randomized controlled trial. Am J Kidney Dis. 2021;78(1):19–27 e11
Liao MT, Chen MK, Hsieh MY, Yeh NL, Chien KL, Lin CC, Wu CC, Chie WC. Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2020;15(4): e0231463.
pubmed: 32287283
pmcid: 7156061
doi: 10.1371/journal.pone.0231463
Bjorkman P, Weselius EM, Kokkonen T, Rauta V, Alback A, Venermo M. Drug-coated versus plain balloon angioplasty in arteriovenous fistulas: a randomized, controlled study with 1-year follow-up (The Drecorest Ii-Study). Scand J Surg. 2019;108(1):61–6.
pubmed: 30182815
doi: 10.1177/1457496918798206
Kitrou PM, Katsanos K, Spiliopoulos S, Karnabatidis D, Siablis D. Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472). Eur J Radiol. 2015;84(3):418–23.
pubmed: 25575743
doi: 10.1016/j.ejrad.2014.11.037
Kitrou PM, Spiliopoulos S, Katsanos K, Papachristou E, Siablis D, Karnabatidis D. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. J Vasc Interv Radiol. 2015;26(3):348–54.
pubmed: 25542635
doi: 10.1016/j.jvir.2014.11.003
Swinnen JJ, Hitos K, Kairaitis L, Gruenewald S, Larcos G, Farlow D, Huber D, Cassorla G, Leo C, Villalba LM, et al. Multicentre, randomised, blinded, control trial of drug-eluting balloon vs Sham in recurrent native dialysis fistula stenoses. J Vasc Access. 2019;20(3):260–9.
pubmed: 30227772
doi: 10.1177/1129729818801556
Kennedy SA, Mafeld S, Baerlocher MO, Jaberi A, Rajan DK. Drug-coated balloon angioplasty in hemodialysis circuits: a systematic review and meta-analysis. J Vasc Interv Radiol. 2019;30(4):483–94.e481
Yan Wee IJ, Yap HY, Hsien Ts'ung LT, Lee Qingwei S, Tan CS, Tang TY, Chong TT. A systematic review and meta-analysis of drug-coated balloon versus conventional balloon angioplasty for dialysis access stenosis. J Vasc Surg. 2019;70(3):970–79.e973
Kitrou PM, Papadimatos P, Spiliopoulos S, Katsanos K, Christeas N, Brountzos E, Karnabatidis D. Paclitaxel-coated balloons for the treatment of symptomatic central venous stenosis in dialysis access: results from a randomized controlled trial. J Vasc Interv Radiol. 2017;28(6):811–7.
pubmed: 28434662
doi: 10.1016/j.jvir.2017.03.007
Falk A, Maya ID, Yevzlin AS, Investigators R. A prospective, randomized study of an expanded polytetrafluoroethylene stent graft versus balloon angioplasty for in-stent restenosis in arteriovenous grafts and fistulae: two-year results of the RESCUE study. J Vasc Interv Radiol. 2016;27(10):1465–76.
pubmed: 27514445
doi: 10.1016/j.jvir.2016.06.014
Haskal ZJ, Saad TF, Hoggard JG, Cooper RI, Lipkowitz GS, Gerges A, Ross JR, Pflederer TA, Mietling SW. Prospective, randomized, concurrently-controlled study of a stent graft versus balloon angioplasty for treatment of arteriovenous access graft stenosis: 2-year results of the RENOVA study. J Vasc Interv Radiol. 2016;27(8):1105–114.e1103
Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, Berman S, McLennan G, Trimmer C, Ross J, et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010;362(6):494–503.
pubmed: 20147715
doi: 10.1056/NEJMoa0902045
Mohr BA, Sheen AL, Roy-Chaudhury P, Schultz SR, Aruny JE, Investigators R. Clinical and economic benefits of stent grafts in dysfunctional and thrombosed hemodialysis access graft circuits in the REVISE randomized trial. J Vasc Interv Radiol. 2019;30(2):203–11.e204.
Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation. 1989;80(6):1726–36
Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, Heffelfinger SC. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001;59(6):2325–34.
pubmed: 11380837
doi: 10.1046/j.1523-1755.2001.00750.x
Lilly RZ, Carlton D, Barker J, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M. Predictors of arteriovenous graft patency after radiologic intervention in hemodialysis patients. Am J Kidney Dis. 2001;37(5):945–53.
pubmed: 11325676
doi: 10.1016/S0272-6386(05)80010-1
Quencer KB, Arici M. Arteriovenous fistulas and their characteristic sites of stenosis. AJR Am J Roentgenol. 2015;205(4):726–34.
pubmed: 26397321
doi: 10.2214/AJR.15.14650
Bittl JA. Catheter interventions for hemodialysis fistulas and grafts. JACC Cardiovasc Interv. 2010;3(1):1–11.
pubmed: 20129561
doi: 10.1016/j.jcin.2009.10.021
Tan TL, May KK, Robless PA, Ho P. Outcomes of endovascular intervention for salvage of failing hemodialysis access. Ann Vasc Dis. 2011;4(2):87–92.
pubmed: 23555435
pmcid: 3595831
doi: 10.3400/avd.oa.10.00009
DePietro DM, Trerotola SO. Choosing the right treatment for the right lesion, Part II: a narrative review of drug-coated balloon angioplasty and its evolving role in dialysis access maintenance. Cardiovasc Diagn Ther. 2023;13(1):233–59.
pubmed: 36864970
pmcid: 9971313
doi: 10.21037/cdt-22-497